ȸ»ç¼Ò°³
ȸ»ç¼Ò°³
Àλ縻
ÇÙ½É ¿ª·®
ÁÖ¿ä »ç¾÷
¿À½Ã´Â ±æ
ÇìµåÇåÆÃ ÀÇ·Ú
ÁÖ¿ä °í°´»ç
ÇìµåÇåÅÍ ¼Ò°³
ÇìµåÇåÆÃ ÇÁ·Î¼¼½º
ÇìµåÇåÆÃ ÀÇ·Ú
ä¿ëÁ¤º¸
ä¿ëÁ¤º¸
ä¿ë ÇÁ·Î¼¼½º
ÀÔ»çÁö¿ø/¹®ÀÇ
ÇìµåÇåÅÍ Ã¤¿ë
ÇìµåÇåÅÍ Ã¤¿ë
ÇìµåÇåÅÍ Áö¿ø
Ä¿¸®¾î Á¤º¸
Ä¿¸®¾î 3ºÐ ÄÚÄ¡
Ä¿¸®¾î ´º½º
To Be your
Great HR Partners
¿ì¸®´Â
º£Å×¶û ÇìµåÇåÅÍ
µéÀÔ´Ï´Ù
ä¿ëÁ¤º¸
ȸ»ç¼Ò°³
ÇìµåÇåÆÃ ÀÇ·Ú
ä¿ëÁ¤º¸
ÇìµåÇåÅÍ Ã¤¿ë
Ä¿¸®¾î Á¤º¸
ä¿ëÁ¤º¸
ä¿ëÁ¤º¸
ä¿ë ÇÁ·Î¼¼½º
ÀÔ»çÁö¿ø/¹®ÀÇ
ä¿ëÁ¤º¸
[¾à¹° °¨½Ã Àü¹® ±â¾÷] Pharmacovigilance Specislist
HIT
¸¶°¨
2025-04-03 | Á¶È¸¼ö : 1280
[¾à¹° °¨½Ã ±â¾÷] IT±âȹ(5³â ÀÌ»ó/ ¼¿ï °³²±¸)
HIT
¸¶°¨
2025-04-03 | Á¶È¸¼ö : 1250
[¾à¹°°¨½Ã Àü¹® ¹ÙÀÌ¿À ±â¾÷] PV(¾à¹°°¨½Ã)Specialist (3-5³â/¼¿ï °³²±¸)
HIT
¸¶°¨
2025-03-14 | Á¶È¸¼ö : 1424
[¹ÙÀÌ¿Àº¥Ã³±â¾÷] CSV Specialist(2³â ÀÌ»ó /¼¿ï °³²±¸)
HIT
¸¶°¨
2025-03-14 | Á¶È¸¼ö : 1316
[¾à¹° °¨½Ã Àü¹® ¹ÙÀÌ¿À ±â¾÷] IT ǰÁú°Ë¼ö ´ã´çÀÚ (ITQA)
HIT
¸¶°¨
2025-03-14 | Á¶È¸¼ö : 1347
[¾à¹° °¨½Ã Àü¹® ¹ÙÀÌ¿À ±â¾÷] ¿µ¾÷(3-5³â /CRO BD/ SaaS ¿µ¾÷)
HIT
¸¶°¨
2025-03-14 | Á¶È¸¼ö : 1374
[¾à¹° °¨½Ã Àü¹® ±â¾÷] PV Expert PVE
HIT
¸¶°¨
2025-03-14 | Á¶È¸¼ö : 1747
[¹ÙÀÌ¿Àº¥Ã³±â¾÷] CSV ÆÀÀå(6³â ÀÌ»ó /¼¿ï °³²±¸)
HIT
¸¶°¨
2025-02-12 | Á¶È¸¼ö : 1369
[¹ÙÀÌ¿Àº¥Ã³±â¾÷] CSV ÆÀ¿ø(2-5³â /¼¿ï °³²±¸)
HIT
¸¶°¨
2025-02-12 | Á¶È¸¼ö : 1400
[Áß¼Ò ÈÀåǰ ±â¾÷] ǰÁú ÆÀÀå (°æ·Â10³â ³»¿Ü)
HIT
¸¶°¨
2025-01-10 | Á¶È¸¼ö : 1246
[Á¦¾à¹ÙÀÌ¿À] Biomaterials Lab (¼®»ç ÀÌ»ó/ 2~5³â / °æ±â ¼º³² ÆÇ±³)
HIT
¸¶°¨
2024-11-19 | Á¶È¸¼ö : 1550
[Á¦¾à¹ÙÀÌ¿À] °³¹ß(RA) ÆÀÀå(12~15³â/ °æ±â ¼º³² ÆÇ±³)
HIT
¸¶°¨
2024-10-23 | Á¶È¸¼ö : 1753
[Á¦¾à¹ÙÀÌ¿À] ÇØ¿Ü RA ÆÀÀå(12~15³â/ °æ±â ¼º³² ÆÇ±³)
HIT
¸¶°¨
2024-10-23 | Á¶È¸¼ö : 1793
[Á¦¾à¹ÙÀÌ¿À] ÇØ¿Ü RA ÆÀ¿ø(3~5³â/ °æ±â ¼º³² ÆÇ±³)
HIT
¸¶°¨
2024-10-23 | Á¶È¸¼ö : 1835
[Á¦¾à¹ÙÀÌ¿À] ÀÇ·á±â±â Àåºñ ¿µ¾÷ ¸¶ÄÉÆÃ(7~12³â/ °æ±â ¼º³² ÆÇ±³)
HIT
¸¶°¨
2024-10-23 | Á¶È¸¼ö : 1625
1
2
3
4
5
6
Á¦¸ñ
ÇìµåÇåÅÍ
³»¿ë